{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:18:42Z","timestamp":1773753522090,"version":"3.50.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174046","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T15:06:58Z","timestamp":1490713618000},"page":"e0174046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B"],"prefix":"10.1371","volume":"12","author":[{"given":"Yi-Jie","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-3039","authenticated-orcid":true,"given":"Yen-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Shun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.27723","article-title":"Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis","volume":"61","author":"JW Jang","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"GV Papatheodoridis","year":"2015","journal-title":"Journal of hepatology"},{"issue":"18","key":"ref3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection","volume":"308","author":"CY Wu","year":"2012","journal-title":"Jama"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1002\/hep.22900","article-title":"Antiviral resistance and hepatitis B therapy","volume":"49","author":"MG Ghany","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"AS Lok","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2010.06.016","article-title":"Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B","volume":"54","author":"W Chotiyaputta","year":"2011","journal-title":"Journal of hepatology"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"YF Liaw","year":"2008","journal-title":"Hepatology international"},{"issue":"33","key":"ref8","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.3748\/wjg.v20.i33.11641","article-title":"Management of antiviral drug resistance in chronic hepatitis B","volume":"20","author":"KB Bang","year":"2014","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection","volume":"57","journal-title":"Journal of hepatology"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cgh.2007.05.004","article-title":"Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B","volume":"5","author":"EB Keeffe","year":"2007","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1053\/j.gastro.2010.04.048","article-title":"Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study","volume":"139","author":"J Liu","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy","volume":"49","author":"DJ Tenney","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2007.12.043","article-title":"Chronic hepatitis B: preventing, detecting, and managing viral resistance","volume":"6","author":"EB Keeffe","year":"2008","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jhep.2008.08.020","article-title":"Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance","volume":"50","author":"B Degertekin","year":"2009","journal-title":"Journal of hepatology"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/jgh.12283","article-title":"Differential roles of serum hepatitis B virus DNA and hepatitis B surface antigen level in predicting virological breakthrough in patients receiving lamivudine therapy","volume":"28","author":"CW Su","year":"2013","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"YF Liaw","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2008.12.019","article-title":"Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B","volume":"51","author":"S Zeuzem","year":"2009","journal-title":"Journal of hepatology"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/jhep.2001.27563","article-title":"Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy","volume":"34","author":"MF Yuen","year":"2001","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2893.2012.01602.x","article-title":"First-line treatment of chronic hepatitis B with entecavir or tenofovir in \u2018real-life\u2019 settings: from clinical trials to clinical practice","volume":"19","author":"S Pol","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2011.09.018","article-title":"Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study","volume":"56","author":"J Petersen","year":"2012","journal-title":"Journal of hepatology"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1111\/jvh.12239","article-title":"Antiviral effect of entecavir in nucleos(t)ide analogue-naive and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy","volume":"21","author":"CH Chen","year":"2014","journal-title":"J Viral Hepat"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.5009\/gnl.2013.7.6.712","article-title":"Continuous Long-Term Entecavir Therapy in Na\u00efve Chronic Hepatitis B Patients Showing Partial Virologic Response","volume":"7","author":"DH Kwon","year":"2013","journal-title":"Gut and Liver"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/hep.24318","article-title":"Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice","volume":"53","author":"C Hongthanakorn","year":"2011","journal-title":"Hepatology (Baltimore, Md)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:09:44Z","timestamp":1540339784000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174046"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]}}}